Dermal Bead
The cosmetic dermatology programme is partnered with Merz Pharmaceuticals GmbH and is focused on the dermal filler market segment.
Dermal filler products address the market for the cosmetic treatment of facial wrinkles and for skin augmentation. They are injected in a non-surgical procedure. Merz selected CellMed’s technology because it was looking for a next-generation material to improve on the products that make up the $900m US market.
The programme has made good progress since signing a co-operation and licence agreement in 2005. After positive clinical data was generated, a CE Mark application was filed in December 2008 and granted in early March 2009. The product has been tested extensively with key opinion leaders throughout Europe and will be launched in the European market in January of 2010. The second step will be to approach the US market.
CE Mark Approval for Cosmetic Dermal Filler Bead (19/03/2009)
Filing for CE Mark Approval for Dermal Filler Bead (12/12/2008)
